212 related articles for article (PubMed ID: 29784450)
21. Post radiation hysterectomy in locally advanced cervical cancer: Outcomes and dosimetric impact.
Mazeron R; Gouy S; Chargari C; Rivin Del Campo E; Dumas I; Mervoyer A; Genestie C; Bentivegna E; Balleyguier C; Pautier P; Morice P; Haie-Meder C
Radiother Oncol; 2016 Sep; 120(3):460-466. PubMed ID: 27492204
[TBL] [Abstract][Full Text] [Related]
22. Pulsed-dose rate image-guided adaptive brachytherapy in cervical cancer: Dose-volume effect relationships for the rectum and bladder.
Mazeron R; Maroun P; Castelnau-Marchand P; Dumas I; del Campo ER; Cao K; Slocker-Escarpa A; M'Bagui R; Martinetti F; Tailleur A; Guemnie-Tafo A; Morice P; Chargari C; Lefkopoulos D; Haie-Meder C
Radiother Oncol; 2015 Aug; 116(2):226-32. PubMed ID: 26164773
[TBL] [Abstract][Full Text] [Related]
23. Health-Related Quality of Life in Locally Advanced Cervical Cancer Patients After Definitive Chemoradiation Therapy Including Image Guided Adaptive Brachytherapy: An Analysis From the EMBRACE Study.
Kirchheiner K; Pötter R; Tanderup K; Lindegaard JC; Haie-Meder C; Petrič P; Mahantshetty U; Jürgenliemk-Schulz IM; Rai B; Cooper R; Dörr W; Nout RA;
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1088-98. PubMed ID: 26876955
[TBL] [Abstract][Full Text] [Related]
24. Bladder accumulated dose in image-guided high-dose-rate brachytherapy for locally advanced cervical cancer and its relation to urinary toxicity.
Zakariaee R; Hamarneh G; Brown CJ; Gaudet M; Aquino-Parsons C; Spadinger I
Phys Med Biol; 2016 Dec; 61(24):8408-8424. PubMed ID: 27845913
[TBL] [Abstract][Full Text] [Related]
25. Lessons from radiochemotherapy and modern image-guided adaptive brachytherapy followed by hysterectomy.
Varela Cagetti L; Zemmour C; Minsat M; Lambaudie E; Houvenaeghel G; Provansal M; Cappiello MA; Rua S; Jauffret C; Ferré M; Mailleux H; Gonzague L; Tallet A
Gynecol Oncol; 2020 Feb; 156(2):328-334. PubMed ID: 31864683
[TBL] [Abstract][Full Text] [Related]
26. MRI- and PET-Guided Interstitial Brachytherapy for Postsurgical Vaginal Recurrences of Cervical Cancer: Results of Phase II Study.
Chopra S; Engineer R; Shah S; Shukla R; Dora T; Gupta P; Paul SN; Popat P; Swamidas J; Mahantshetty U; Varghese L; Gupta S; Rangrajan V; Shrivastava S
Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):310-319. PubMed ID: 31682968
[TBL] [Abstract][Full Text] [Related]
27. Intermediate-term results of image-guided brachytherapy and high-technology external beam radiotherapy in cervical cancer: Chiang Mai University experience.
Tharavichitkul E; Chakrabandhu S; Wanwilairat S; Tippanya D; Nobnop W; Pukanhaphan N; Galalae RM; Chitapanarux I
Gynecol Oncol; 2013 Jul; 130(1):81-5. PubMed ID: 23603369
[TBL] [Abstract][Full Text] [Related]
28. Predictors of toxicity after image-guided high-dose-rate interstitial brachytherapy for gynecologic cancer.
Lee LJ; Viswanathan AN
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1192-7. PubMed ID: 22592049
[TBL] [Abstract][Full Text] [Related]
29. MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective.
Lindegaard JC; Fokdal LU; Nielsen SK; Juul-Christensen J; Tanderup K
Acta Oncol; 2013 Oct; 52(7):1510-9. PubMed ID: 23962242
[TBL] [Abstract][Full Text] [Related]
30. Late side effects of 3T MRI-guided 3D high-dose rate brachytherapy of cervical cancer : Institutional experiences.
Vojtíšek R; Sukovská E; Baxa J; Budíková M; Kovářová P; Fínek J
Strahlenther Onkol; 2019 Nov; 195(11):972-981. PubMed ID: 31309266
[TBL] [Abstract][Full Text] [Related]
31. Vaginal Dose Is Associated With Toxicity in Image Guided Tandem Ring or Ovoid-Based Brachytherapy.
Susko M; Craciunescu O; Meltsner S; Yang Y; Steffey B; Cai J; Chino J
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1099-105. PubMed ID: 26883564
[TBL] [Abstract][Full Text] [Related]
32. D2cm³/DICRU ratio as a surrogate of bladder hotspots localizations during image-guided adaptive brachytherapy for cervical cancer: assessment and implications in late urinary morbidity analysis.
Mazeron R; Dumas I; Rivin E; Martin V; Benhabib-Boukhelif W; Tailleur A; Guemnie-Tafo A; Martinetti F; Chargari C; Lefkopoulos D; Haie-Meder C
Brachytherapy; 2015; 14(2):300-7. PubMed ID: 25442061
[TBL] [Abstract][Full Text] [Related]
33. Treatment of locally advanced vaginal cancer with radiochemotherapy and magnetic resonance image-guided adaptive brachytherapy: dose-volume parameters and first clinical results.
Dimopoulos JC; Schmid MP; Fidarova E; Berger D; Kirisits C; Pötter R
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1880-8. PubMed ID: 21868174
[TBL] [Abstract][Full Text] [Related]
34. MRI-guided brachytherapy in locally advanced cervical cancer: Small bowel [Formula: see text] and [Formula: see text] are not predictive of late morbidity.
Petit C; Dumas I; Chargari C; Martinetti F; Maroun P; Doyeux K; Tailleur A; Haie-Meder C; Mazeron R
Brachytherapy; 2016; 15(4):463-470. PubMed ID: 27180130
[TBL] [Abstract][Full Text] [Related]
35. Clinical outcomes of definitive chemoradiation followed by intracavitary pulsed-dose rate image-guided adaptive brachytherapy in locally advanced cervical cancer.
Castelnau-Marchand P; Chargari C; Maroun P; Dumas I; Del Campo ER; Cao K; Petit C; Martinetti F; Tafo-Guemnie A; Lefkopoulos D; Morice P; Haie-Meder C; Mazeron R
Gynecol Oncol; 2015 Nov; 139(2):288-94. PubMed ID: 26364808
[TBL] [Abstract][Full Text] [Related]
36. Hybrid TRUS/CT with optical tracking for target delineation in image-guided adaptive brachytherapy for cervical cancer.
Smet S; Nesvacil N; Knoth J; Sturdza A; Najjari-Jamal D; Jelinek F; Kronreif G; Pötter R; Widder J; Kirisits C; Schmid MP
Strahlenther Onkol; 2020 Nov; 196(11):983-992. PubMed ID: 32621011
[TBL] [Abstract][Full Text] [Related]
37. Severity and Persistency of Late Gastrointestinal Morbidity in Locally Advanced Cervical Cancer: Lessons Learned From EMBRACE-I and Implications for the Future.
Spampinato S; Jensen NBK; Pötter R; Fokdal LU; Chargari C; Lindegaard JC; Schmid MP; Sturdza A; Jürgenliemk-Schulz IM; Mahantshetty U; Hoskin P; Segedin B; Rai B; Bruheim K; Wiebe E; Van der Steen-Banasik E; Cooper R; Van Limbergen E; Sundset M; Pieters BR; Lutgens LCHW; Tan LT; Villafranca E; Smet S; Jastaniyah N; Nout RA; Kirisits C; Chopra S; Kirchheiner K; Tanderup K; Embrace Collaborative Group
Int J Radiat Oncol Biol Phys; 2022 Mar; 112(3):681-693. PubMed ID: 34678431
[TBL] [Abstract][Full Text] [Related]
38. Late, Persistent, Substantial, Treatment-Related Symptoms After Radiation Therapy (LAPERS): A New Method for Longitudinal Analysis of Late Morbidity-Applied in the EMBRACE Study.
Kirchheiner K; Pötter R; Nout RA; Schwartz-Vittrup A; Holzner B; Bentzen SM; Tanderup K
Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):300-309. PubMed ID: 31669565
[TBL] [Abstract][Full Text] [Related]
39. Risk Factors for Local Failure Following Chemoradiation and Magnetic Resonance Image-Guided Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study.
Schmid MP; Lindegaard JC; Mahantshetty U; Tanderup K; Jürgenliemk-Schulz I; Haie-Meder C; Fokdal LU; Sturdza A; Hoskin P; Segedin B; Bruheim K; Huang F; Rai B; Cooper R; van der Steen-Banasik E; Van Limbergen E; Pieters BR; Petric P; Ramazanova D; Ristl R; Kannan S; Hawaldar R; Ecker S; Kirchheiner K; Tan LT; Nout R; Nesvacil N; de Leeuw A; Pötter R; Kirisits C;
J Clin Oncol; 2023 Apr; 41(10):1933-1942. PubMed ID: 36599120
[TBL] [Abstract][Full Text] [Related]
40. Treatment outcomes of MRI-guided adaptive brachytherapy in patients with locally advanced cervical cancer: institutional experiences.
Vojtíšek R; Hošek P; Sukovská E; Kovářová P; Baxa J; Ferda J; Fínek J
Strahlenther Onkol; 2022 Sep; 198(9):783-791. PubMed ID: 35059759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]